[Federal Register Volume 71, Number 238 (Tuesday, December 12, 2006)]
[Notices]
[Pages 74485-74486]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-20946]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Order No. 1496]


Grant Of Authority For Subzone Status, Merck & Co., Inc., 
(Vaccine Pharmaceuticals), Durham, North Carolina

    Pursuant to its authority under the Foreign-Trade Zones Act of 
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade 
Zones Board (the Board) adopts the following Order:
    Whereas, the Foreign-Trade Zones Act provides for `` . . . the 
establishment . . . of foreign-trade zones in ports of entry of the 
United States, to expedite and encourage foreign commerce, and for 
other purposes,'' and authorizes the Foreign-Trade Zones Board to grant 
to qualified corporations the privilege of establishing foreign-trade 
zones in or adjacent to U.S. Customs and Border Protection ports of 
entry;
    Whereas, the Board's regulations (15 CFR Part 400) provide for the 
establishment of special-purpose subzones when existing zone facilities 
cannot serve the specific use involved,

[[Page 74486]]

and when the activity results in a significant public benefit and is in 
the public interest;
    Whereas, the Triangle J Council of Governments, grantee of FTZ 93, 
has made application to the Board for authority to establish special-
purpose subzone status at the vaccine pharmaceutical manufacturing 
plant of Merck & Co., Inc., located in Durham, North Carolina (FTZ 
Docket 64-2005, filed 12/15/05);
    Whereas, notice inviting public comment has been given in the 
Federal Register (70 FR 76444, 12/27/05); and, WHEREAS, the Board 
adopts the findings and recommendations of the examiner's report, and 
finds that the requirements of the FTZ Act and the Board's regulations 
are satisfied, and that approval of the application is in the public 
interest;
    Now therefore, the Board hereby grants authority for subzone status 
for activity related to vaccine pharmaceutical manufacturing at the 
Merck & Co., Inc., facility located in Durham, North Carolina (Subzone 
93H), as described in the application and Federal Register notice, and 
subject to the FTZ Act and the Board's regulations, including Section 
400.28.
    Signed at Washington, DC, this 1st day of December 2006.

David M. Spooner,
Assistant Secretary of Commerce for Import Administration, Alternate 
Chairman, Foreign-Trade Zones Board
    Attest:
Andrew McGilvray,
Acting Executive Secretary.
[FR Doc. E6-20946 Filed 12-8-06; 8:45 am]
BILLING CODE 3510-DS-S